Breast Cancer Research and Treatment

Papers
(The H4-Index of Breast Cancer Research and Treatment is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia138
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer114
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study73
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer66
The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study56
Predicting the likelihood of carrying BRCA1 or BRCA2 pathogenic variants in high-risk Pakistani breast cancer patients48
Integrating SENOMAC and AMAROS: a call for de-escalation47
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study41
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients40
Correction: Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy39
Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health system38
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials35
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis35
Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival34
Temporal patterns of breast cancer incidence, mortality, disability-adjusted life years and risk factors in 12 South American Countries, 1990–2019: an examination using estimates from the global burde32
Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis32
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer32
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database30
Risk of myocardial infarction and stroke after breast cancer: an analysis of a population of 1.3 million women from North-West Italy29
Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study27
Intraoperative assessment of axillary sentinel lymph nodes by telepathology27
Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study27
Inter-reader agreement of breast magnetic resonance imaging and contrast-enhanced mammography in breast cancer diagnosis: a multi-reader retrospective study26
Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis26
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study26
Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis26
0.23355793952942